Study to Assess if ABP710 is Safe & Effective in Treating Moderate to Severe Rheumatoid Arthritis Compared to Infliximab
Clinical trial NCT02937701 · COMPLETED
Trial details
- NCT number
- NCT02937701
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-10
- Primary completion
- 2018-04-16
- Enrollment
- 558
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.